Why I Joined a Clinical Trial
I did it not so much for me, but for my children and grandchildren. Hope that this drug will help eliminate polyps.Clinical Trials Search
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and... | Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo | NCT03578081 | Alliance for Clinical Trials in Oncology | Recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2... | Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment | NCT03633331 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil | Donepezil 5 mg, Placebo | NCT02822573 | Wake Forest University Health Sciences | Recruiting |
| Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk | Metformin, Placebo | NCT02028221 | University of Arizona | Active, not recruiting |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | Questionnaire Administration, Placebo Administration, Endoxifen Hydrochloride | NCT03317405 | National Cancer Institute (NCI) | Active, not recruiting |
| Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... | Denosumab, Salpingo-Oophorectomy | NCT03382574 | National Cancer Institute (NCI) | Recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... | Endocrine therapy interruption | NCT02308085 | International Breast Cancer Study Group | Active, not recruiting |
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | Pamidronate, Calcium and vitamin D | NCT02074631 | Masonic Cancer Center, University of Minnesota | Recruiting |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT03036930 | National Cancer Institute (NCI) | Active, not recruiting |
| PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... | Laboratory Biomarker Analysis, Rilimogene Galvacirepvec, Placebo Administration | NCT02326805 | National Cancer Institute (NCI) | Active, not recruiting |